Metraipolis › archive › dc_67b77e58dbfc

Efficacy of tepotinib in patients with high-grade glioma with MET alterations: A case series — Europe PMC PMID:42111027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42111027
DOI
10.1093/nop/npaf130
License (as archived)
solo-consultazione
Archived
2026-11-07T07:15:34.405Z
SHA-256 of the archived text
a23b02cd1436380d947d3ce56aada035b99fd374432122b5a9dad5ffeb4d4493
Stable URL of this page
https://metraipolis.com/documento/dc_67b77e58dbfc

How to cite

Efficacy of tepotinib in patients with high-grade glioma with MET alterations: A case series — Europe PMC PMID:42111027 — Europe PMC (en), https://europepmc.org/article/MED/42111027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67b77e58dbfc (Metraipolis archive dc_67b77e58dbfc, sha256 a23b02cd1436380d947d3ce56aada035b99fd374432122b5a9dad5ffeb4d4493)
BibTeX
@misc{dc67b77e58dbfc,
  title = {Efficacy of tepotinib in patients with high-grade glioma with MET alterations: A case series — Europe PMC PMID:42111027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42111027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67b77e58dbfc; sha256 a23b02cd1436380d947d3ce56aada035b99fd374432122b5a9dad5ffeb4d4493},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42111027. Agents can read the archived copy with the MCP tool read_document.